 |
||||||
|---|---|---|---|---|---|---|
 |
 |
 |
 |
 |
 |
|
 |
|||
|---|---|---|---|
  |
|||
TheraTears was developed by Jeffrey P. Gilbard, MD, in the clinics and laboratories of the Schepens Eye Research Institute. The Schepens Eye Research Institute is the largest nonprofit institution in the world dedicated to the fight against blinding and painful eye conditions. Arising from this heritage, Advanced Vision Research remains committed to eye research and the mission of developing major advances in the treatment of eye disease. |
|||
 |
|||
 |
In the summer of 1976, as a medical student, Dr. Gilbard met his first patient with dry eyes and decided something had to be done. What began as a summer research project turned into one of the most productive dry eye research programs in the world. In 1978 he received project grant funding from the National Eye Institute, and to this day he remains the youngest scientist in history to have received such funding. His research program had one goal — to develop an eye drop for dry eye that really worked. His 18-year research program was successful. Dr. Gilbard is now Founder, CEO and Chief Scientific Officer of Advanced Vision Research, Clinical Assistant Professor of Ophthalmology at Harvard Medical School. |
||
 |
|||
Every box of TheraTears comes with a Satisfaction Guarantee. If you are not completely satisfied with this product, please call 1-800-979-8327. |
|||
|
|||
|
|||
 |
 |
||||
|---|---|---|---|---|---|
 |
 |
 |
 |
 |
|
 |
|||||
